RxDoctor Payments Data

Chad Boomershine

Rheumatology · Nashville, TNNPI 1457408304

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $8,030 of the $9,700 with a category attached, or 82.8%. 24 manufacturers reported payments, led by Pfizer at 46.3% of the total. Reporting peaked in 2019 at $4,912 and has fallen 99.7% since, to $16 in 2023.

$9,700in general payments, 2019–2025

Across 73 payments — averaging $132.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$4K
  • Regeneron$4K
  • UCB, Inc.$282
  • Amgen$163
  • Regeneron Healthcare Solutions, Inc.$121
  • AbbVie$118
  • plus $649 from 18 others
$94,970in research payments, 2019–2025

Across 24 payments — averaging $3957.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi US Services Inc.$85K
  • Shionogi Inc$5K
  • Pfizer$2K
  • Amgen$2K
  • Regeneron$333

What the payments were for

  • Consulting fees$8,03083%
  • Travel & lodging$3373%
  • Food & beverage$1,31814%
  • Education$150%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,700 in reported general payments places this provider in the 65th percentile of 127 rheumatology providers in Tennessee.

See all rheumatology providers in Tennessee

Other rheumatology in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →